Elanco Animal Health (ELAN) Depreciation & Amortization (CF) (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $172.0 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 6.83% year-over-year to $172.0 million; the trailing twelve-month figure through Mar 2026 stood at $691.0 million (up 5.18% YoY), and the FY2025 full-year result was $680.0 million, up 2.72% from the prior year.
• Depreciation & Amortization (CF) eased to $172.0 million in Q1 2026, from $174.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $177.0 million in Q2 2023 to a low of $161.0 million in Q1 2025.
• A 5-year average of $170.0 million and a median of $171.0 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) declined 12.87% in 2022 and grew 6.83% in 2026, its largest moves.
• Tracing ELAN's Depreciation & Amortization (CF) over 5 years: stood at $168.0 million in 2022, then gained by 1.79% to $171.0 million in 2023, then declined by 4.09% to $164.0 million in 2024, then advanced by 6.1% to $174.0 million in 2025, then fell by 1.15% to $172.0 million in 2026.
• Business Quant data shows ELAN's Depreciation & Amortization (CF) at $172.0 million in Q1 2026, $174.0 million in Q4 2025, and $176.0 million in Q3 2025.